Scott Applebaum's most recent trade in Cingulate Inc was a trade of 15,000 Stock Option (right to Buy) done . Disclosure was reported to the exchange on June 15, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cingulate Inc | Scott Applebaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to Buy) | |
Cingulate Inc | Scott Applebaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 12,000 | 12,000 | - | - | Stock Option (right to Buy) | |
Trevena Inc | Scott Applebaum | CLCO; SVP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. | 10 Feb 2021 | 21,178 | 344,022 (0%) | 0% | 2.8 | 60,357 | Common Stock |
Trevena Inc | Scott Applebaum | CLCO; SVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 172,750 | 172,750 | - | - | Stock Option (Right to Buy) | |
Trevena Inc | Scott Applebaum | CLCO; SVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 115,200 | 365,200 (0%) | 0% | 0 | Common Stock |